Clinical trial
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes…
NCT00079911 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00079911 |
|---|---|
| Title | A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons |
| Official title | An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons With CD4+ Lymphocyte Count <100 Cells/mm3. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Herpes Genitalis |
| Intervention type | Drug |
| Interventions | valacyclovir hydrochloride |
| Enrollment | 7 |
| Start date | Mar 12, 2004 |
| Primary completion | Oct 15, 2004 |
| Completion | Oct 15, 2004 |
| First posted | Mar 19, 2004 |
| Last update posted | Nov 24, 2020 |
| Countries | Australia, Hong Kong, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: